This inventor holds 1 USPTO granted patent. Top assignee: Aviv Therapeutics, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Yie-Teh Yu: Innovator in Mitochondrial Research
Introduction
Yie-Teh Yu is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of mitochondrial research, particularly in the development of compounds that target mitochondrial aldehyde dehydrogenase-2 (ALDH2). His work aims to provide therapeutic solutions for patients suffering from Fanconi Anemia.
Latest Patents
Yie-Teh Yu holds a patent for "Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof." This invention presents compounds that bind to ALDH2, along with methods for utilizing these compounds in treatment and preparation.
Career Highlights
Yu is currently associated with Aviv Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key figure in the exploration of mitochondrial therapies.
Collaborations
Yie-Teh Yu collaborates with talented individuals such as Wenjin Yang and Chun Jiang, contributing to a dynamic research environment focused on groundbreaking discoveries.
Conclusion
Yie-Teh Yu's work in mitochondrial research exemplifies the impact of innovation in medicine. His contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile